Company: MLSS
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001437749-25-026919
Chunk: 13

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
EDA program, the Company must retain a physical presence in the state of New Jersey for a period of5years after the sale of the NOLs. If the Company does notretain a physical presence during the5years after the sale of the NOLs, the Company can be liable to pay the state of New Jersey up to $2.2million of the surrendered NOLs

NOTE10 - SEGMENT AND GEOGRAPHIC DATA

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (the “ CODM”). The Company conducts its business through tworeportable segments: Dental and Medical. These segments offer different products and services to different customer base. The CODM assesses the financial performance of the segment and decides how to allocate resources based on Product sales, net, and Operating income (loss).

The Company provides general corporate services to its segments; however, these services are notconsidered when making operating decisions and assessing segment performance. These services are reported under “ Corporate Services” below and these include costs associated with executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities and public company compliance.

The following tables present information about our reportable and operating segments for the threeand sixmonths endedJune 30, 2025, and2024:

                                                  Three Months ending June 30, 2025                                             
                                                  Corporate                                                                     
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Product sales, net                              -                                      2,291,366       32,100      2,323,466  
  Cost of products sold                           -                                        704,866          994        705,860  
  Gross Margin                                    -                                      1,586,500       31,106      1,617,606  
  Salaries & employee benefits                    206,777                                  440,463      192,733        839,973  
  Stock-based compensation expense                159,678                                        -            -        159,678  
  Royalty expense                                 -                                        118,174        1,605        119,779  
  Marketing                                       10,156                                    48,047       19,907         78,110  
  Rent & occupancy costs                          21,